These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2403761)

  • 1. Preoperative assessment of malignant hepatic tumors.
    Sitzmann JV; Coleman J; Pitt HA; Zerhouni E; Fishman E; Kaufman SL; Order S; Grochow LB; Cameron JL
    Am J Surg; 1990 Jan; 159(1):137-42; discussion 142-3. PubMed ID: 2403761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of gadoxetic acid-enhanced magnetic resonance imaging in the preoperative evaluation of small hepatic lesions in patients with colorectal cancer.
    Cho JY; Lee YJ; Han HS; Yoon YS; Kim J; Choi Y; Shin HK; Lee W
    World J Surg; 2015 May; 39(5):1161-6. PubMed ID: 25609116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
    Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings.
    Kuszyk BS; Bluemke DA; Urban BA; Choti MA; Hruban RH; Sitzmann JV; Fishman EK
    AJR Am J Roentgenol; 1996 Jan; 166(1):91-5. PubMed ID: 8571914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of CT, MRI and CT during arterial portography in the detection of malignant hepatic lesions.
    Kehagias D; Metafa A; Hatziioannou A; Mourikis D; Vourtsi A; Prahalias A; Smyrniotis V; Gouliamos A; Vlahos L
    Hepatogastroenterology; 2000; 47(35):1399-403. PubMed ID: 11100361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative ultrasound of the liver in primary and secondary hepatic malignancies: comparison with preoperative 1.5-T MRI and 64-MDCT.
    Wagnetz U; Atri M; Massey C; Wei AC; Metser U
    AJR Am J Roentgenol; 2011 Mar; 196(3):562-8. PubMed ID: 21343497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography.
    Dill-Macky MJ; Asch M; Burns P; Wilson S
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S287-95. PubMed ID: 16632690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superiority of CT arterioportal angiography to contrast-enhanced CT and MRI in the diagnosis of hepatocellular carcinoma in nodules smaller than 2 cm.
    Kim SR; Ando K; Mita K; Fuki S; Ikawa H; Kanbara Y; Imoto S; Matsuoka T; Hayashi Y; Kudo M
    Oncology; 2007; 72 Suppl 1():58-66. PubMed ID: 18087183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
    Kim YK; Kwak HS; Han YM; Kim CS
    J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of gadoxetic acid (Primovist)-enhanced MR imaging versus CT during hepatic arteriography and portography for small hypervascular hepatocellular carcinoma.
    Yim SY; Park BJ; Um SH; Han NY; Sung DJ; Cho SB; Lee SH; Kim MJ; Jung JY; Kim JD; Seo YS; Kim DS; An H; Kim YH
    Medicine (Baltimore); 2016 Sep; 95(39):e4903. PubMed ID: 27684824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative determination of the resectability of hepatic tumors: efficacy of CT during arterial portography.
    Small WC; Mehard WB; Langmo LS; Dagher AP; Fishman EK; Heiken JP; Bernardino ME
    AJR Am J Roentgenol; 1993 Aug; 161(2):319-22. PubMed ID: 8333369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma.
    Young K; Fidelman N; Yao FY; Hills NK; Kohi MP; Kolli KP; Taylor AG; Kerlan RK
    Liver Transpl; 2015 Apr; 21(4):454-67. PubMed ID: 25678220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of superparamagnetic iron oxide particle (AMI-25) enhanced MR imaging for the diagnosis of liver tumors: comparison with contrast enhanced CT].
    Hirohashi S; Hirohashi R; Uchida H; Kachi K; Ohtomo K; Uchiyama G; Niitsu M; Itai Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jul; 54(8):776-83. PubMed ID: 8072868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
    Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
    J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation.
    Nelson RC; Chezmar JL; Sugarbaker PH; Bernardino ME
    Radiology; 1989 Jul; 172(1):27-34. PubMed ID: 2662254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factor assessment to predict the likelihood of a diagnosis of metastasis for indeterminate hepatic lesions found at computed tomography in patients with rectal cancer.
    Kang KA; Jang KM; Kim SH; Kang TW; Cha DI
    Clin Radiol; 2017 Jun; 72(6):473-481. PubMed ID: 28258741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results.
    Jung EM; Schreyer AG; Schacherer D; Menzel C; Farkas S; Loss M; Feuerbach S; Zorger N; Fellner C
    Clin Hemorheol Microcirc; 2009; 43(1-2):57-69. PubMed ID: 19713601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
    Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
    Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.